-
These areas are basically monopolized by foreign-funded ecological chain companies that have begun to show their prowess
Time of Update: 2021-08-28
In fact, the capital market’s preference for Yiqiao Shenzhou is also the epitome of the domestic development of upstream products (reagents/consumables/instruments) in the life sciences industry chain: less layout and stuck necks .
-
What protective measures should be taken during the operation of 2N hydrochloric acid
Time of Update: 2021-08-28
2N hydrochloric acid is a substance that we must pay attention to when operating, we need to take relevant protective measures, because if it directly touches our skin or inhales it, it will have a big impact on the body, and we should take relevant protections.
-
The popularity is close to PD-1!
Time of Update: 2021-08-28
This is a small molecule immunotherapy targeting CD47-SIRPα and is currently undergoing phase III clinical trials for small cell lung cancer indications .
-
Catch up while advancing, is there any shortcut for China's mRNA industry?
Time of Update: 2021-08-28
At the same time, because mRNA has a complex secondary structure, its expanded spatial rotating sphere is large, which makes delivery difficult; for this reason, even at present The head company BioNTech also had to change its original delivery system (LPX) to LNP, and Moderna directly used the LNP delivery system that belongs to Arbutus, at the risk of being sued for the first time .
-
incredible! Class 1 new drugs sold 10 billion, innovative drug companies "strike" the 100 billion tumor drug market, and 16 Class 1 new drugs are on the way
Time of Update: 2021-08-28
Sales of terminal protein kinase inhibitors in public medical institutions in China (unit: ten thousand yuan) Source: Mi Nei. com, China's public medical institutions terminal competition pattern With the increasing popularity of tinib drugs, Betta Pharmaceuticals has faced many challenges during the ten years when icotinib was launched on the market, including medical insurance negotiations, a 76.
-
2021 Shanghai Academic Ranking of World Universities: West Lake University is listed for the first time, and Sun Yat-sen University enters the world's top 100
Time of Update: 2021-08-28
On August 15, 2021, Shanghairanking officially released the "2021 Shanghairanking World University Academic Rankings" .
The rankings show the world's leading 1,000 research universities.
Tsinghua University ranks 28th in the world.
Sun Yat-sen University ranks among the world's 100th for the first time.
-
How does the ceiling of the CXO industry push up?
Time of Update: 2021-08-28
WuXi AppTec's quarter-on-quarter growth and year-on-year growth from 2018Q1 to 2021Q2 (click to enlarge) Source: Company announcement, Zhongkang Industrial Capital Research Center Main business and incomeMain business and income Currently, most pharmaceutical R & D services industry (CXO) is a company focused on the stage of drug development, such as drug discovery CRO, preclinical CRO, Clinical CRO, CDMO, CMO and so on .
-
Uses and physicochemical properties of sodium carbonate (anhydrous)
Time of Update: 2021-08-28
To meet the needs of consumers, what are the main contents of the use and physical and chemical properties of sodium carbonate (anhydrous)?
What are the main uses and physical and chemical properties of sodium carbonate (anhydrous) ?
-
Good news I Zejing Pharmaceuticals, Donafenib Tosylate Tablets, Successfully Phase III Clinical Trial in the Treatment of Iodine-Refractory Differentiated Thyroid Cancer
Time of Update: 2021-08-28
Recently, Zejing Pharmaceutical Donafinil Tosylate Tablets (hereinafter referred to as "donafinil") in the treatment of locally advanced/metastatic radioiodine refractory differentiated thyroid cancer (RAIR-DTC) is a multi-center, random, double The blinded, placebo-controlled Phase III clinical trial (code: ZGDD3) carried out a predetermined interim analysis, and the Independent Data Monitoring Committee (IDMC) reviewed the results and determined that the effectiveness and safety results were in line with expectations .
-
Express is expected to bring a full oral treatment plan for hepatitis B functional cure, complete the first administration of RNA destabilizer
Time of Update: 2021-08-28
On August 16, 2021, Enanta Pharmaceuticals announced that the phase 1 clinical trial of EDP-721 has completed the first administration . EDP-721 is a new oral RNA destabilizing agent (destabilizer)
-
A pioneer of domestically-made innovative drugs, the Phase III clinical study of Xinda Biologicals for the treatment of adenocarcinoma of the stomach or gastroesophageal junction reached the primary research endpoint of overall survival
Time of Update: 2021-08-28
On August 16, Innovent announced that the innovative drug PD-1 inhibitor Daboshu® jointly developed with Eli Lilly combined with chemotherapy (oxaliplatin + capecitabine) for the first-line treatment of unresectable locally advanced and recurrent unresectable Or metastatic gastric or gastroesophageal junction adenocarcinoma, a randomized, double-blind, multi-center phase III clinical trial interim analysis reached the primary research endpoint .
-
Notice on the Public Solicitation of Opinions on the Technical Guidelines for Clinical Trials of Generic Drugs of Oral Inhalation Preparations That Have Been Marketed Abroad and Domestically Unmarketed (Draft for Public Comment)
Time of Update: 2021-08-28
docx Annex 3 : "Technical Guidelines for Clinical Trials of Generic Drugs of Oral Inhalation Formulations (Draft for Public Comment) that have been marketed overseas and have not been marketed in China" Opinion Feedback Form.
-
Innovent announces that the Phase III clinical study of IBI306 (anti-PCSK-9 monoclonal antibody) for the treatment of Chinese heterozygous familial hypercholesterolemia has reached the primary research endpoint
Time of Update: 2021-08-28
A biopharmaceutical company, an innovative drug for diseases, announced today: a recombinant fully human anti-proprotein convertase subtilisin 9 (PCSK-9) monoclonal antibody injection (R&D code: IBI306) independently developed by Cinda Bio to treat China The phase III clinical study of heterozygous familial hypercholesterolemia (HeFH) (research code CREDIT-2) reached the primary endpoint .
-
Amgen's new psoriasis drug, Apomilast tablets, approved for marketing
Time of Update: 2021-08-28
In February 2021, Amgen submitted a listing application for Apomilast in China and was included in the priority review for the treatment of psoriasis .
According to the Insight database, in addition to Amgen, there are six domestic companies whose applications for the listing of Apmaster tablets are under review .
-
The first domestic dual antibody ADC: Baili Pharmaceutical BL-B01D1
Time of Update: 2021-08-28
According to the information of Baili Pharmaceutical and its subsidiary SystImmune, BL-B01D1 is a new dual-anti-ADC drug .
Up to now, Bailey Pharmaceuticals has declared 2 double antibodies, 3 quaternary antibodies and 1 double anti-ADC new drug .
-
P53's good partner MDM2, a potential heavy target?
Time of Update: 2021-08-28
1 Representative small molecules targeting P53 and/or MDM2 in clinical trials (Image source: European Journal of Medicinal Chemistry) The first P53-MDM2 protein-protein interaction inhibitor to enter clinical research was developed by Roche Pharmaceuticals, RG7112.
-
Zhejiang medical service prices: 4 situations trigger adjustments, 4 situations cannot be increased!
Time of Update: 2021-08-28
Gradually unify the prices of medical services within the jurisdiction, and establish relatively reasonable price comparisons among different levels of medical institutions such as provinces, cities, and counties The medical insurance departments at the provincial level and in the districts and cities shall take the lead in researching and formulating plans, and allocate space to improved projects and new projects in a reasonable manner .
-
Is ethanol easy to volatilize at room temperature
Time of Update: 2021-08-28
In the real, so when you want to use ethanol, you need to check the manual in time .
After understanding the question of whether ethanol is easy to volatilize at room temperature, you can regard it as a knowledge point.
-
Novo Nordisk's IL-6 inhibitor Ziltivekimab clinical application accepted by NMPA
Time of Update: 2021-08-28
With the positive results of phase II clinical studies in patients with high-risk atherosclerotic chronic kidney disease (CKD), Novo Nordisk remains optimistic about Ziltivekimab and believes that the drug is expected to become a population that can reduce the risk of adverse cardiovascular events.
-
CXO track is not fragrant anymore?
Time of Update: 2021-08-28
And on August 17 (today), Hillhouse's focus on overseas investment in the secondary market fund managers subject HHLR Advisors announced 2021 second quarter data, US stocks 13F positions, continue to heavily loaded Baiji Divine, day environment biology .
